NASDAQ:GLPG
Galapagos NV Stock News
$32.95
+0.240 (+0.734%)
At Close: Mar 27, 2024
Why Galapagos Trounced the Market Today
06:07pm, Thursday, 27'th Jan 2022
A high-profile healthcare industry executive has been tapped as the company's new CEO.
Galapagos at a six-month high after naming former J&J science chief as CEO
03:56pm, Thursday, 27'th Jan 2022 Seeking Alpha
Galapagos <> ADRs have recorded the biggest intraday gain since March 2019 to reach a six-month high after announcing that Paul Stoffels, former chief scientific officer at Johnson
Mid-Morning Market Update: US Markets Open Higher As GDP Rises 6.9% In Fourth Quarter
03:15pm, Thursday, 27'th Jan 2022 Benzinga
US stocks opened on a strong note on Thursday after the country’s economy grew 6.9% on quarter during the last three months of previous year, up from 2.3% expansion in the prior quarter and also above market estimates of 5.5%. Following the market opening, the Dow traded up 1.43% to 34,657.34 while the NASDAQ rose 1.27% to 13,714.18. The S&P also rose, gaining, 1.43% to 4,412.35. Also check out these big insider trades here Leading and Lagging Sectors Energy shares jumped 2.1% on Thursday. Meanwhile, top gainers in the sector included FLEX LNG Ltd. (NYSE: FLNG ), up 7% and Clean Energy Fuels Corp. (NASDAQ: CLNE ) up 8%. In trading on Thursday, consumer discretionary shares rose by just 0.6%. Top Headline McDonald''s Corporation (NYSE: MCD ) reported weaker-than-expected results for its fourth quarter. McDonald''s reported adjusted earnings of $2.23 per share, missing the consensus of $2.34 per share. Net sales came in at $6.01 billion, versus the consensus of $6.03 billion. Equities Trading UP The National Security Group, Inc. (NASDAQ: NSEC ) shares shot up 68% to $15.08 after VR Insurance announced acquisition of the company.
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
12:57pm, Thursday, 27'th Jan 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Atara To Sell Manufacturing Plant to Fuji's CDMO Unit For $100M
Atara Biotherapeutics, Inc. (NASDAQ: A
Galapagos creates 1M subscription rights
10:09pm, Wednesday, 26'th Jan 2022 Seeking Alpha
Galapagos (GLPG) said its supervisory board created 1M subscription rights under a new plan for the benefit of a company personnel
Galapagos creëert nieuw inschrijvingsrechtenplan
09:40pm, Wednesday, 26'th Jan 2022 GlobeNewswire Inc.
Mechelen, België; 26 januari 2022, 22.40 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) kondigt vandaag aan dat haar raad van toezicht 1.000.000 inschrijvingsrechten he
Galapagos creates new subscription right plan
09:40pm, Wednesday, 26'th Jan 2022 GlobeNewswire Inc.
Mechelen, Belgium; 26 January 2022, 22.40 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its supervisory board created 1,000,000 subscription rights under
Galapagos ropes in Paul Stoffels as CEO
09:09pm, Wednesday, 26'th Jan 2022 Seeking Alpha
Galapagos (GLPG) names Paul Stoffels as CEO, effective Apr. 1.Stoffels will be replacing Onno van de Stolpe, who is retiring and will remain for a transition period till Apr
Galapagos benoemt Paul Stoffels tot Chief Executive Officer
09:01pm, Wednesday, 26'th Jan 2022 GlobeNewswire Inc.
Mechelen, België; 26 januari 2022, 22.01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) is verheugd per 1 april 2022 de benoeming van Dr. Paul Stoffels als Chief Executiv
Galapagos appoints Paul Stoffels as Chief Executive Officer
09:01pm, Wednesday, 26'th Jan 2022 GlobeNewswire Inc.Drugmaker Galapagos names former J&J exec Paul Stoffels as CEO
06:01pm, Wednesday, 26'th Jan 2022
Belgian drugmaker Galapagos NV on Wednesday named former Johnson & Johnson senior executive Paul Stoffels as its chief executive officer, effective April 1.
Einhorn''s Greenlight takes new positions in Global Payments, Capri, Galapagos
03:13pm, Wednesday, 26'th Jan 2022 Seeking Alpha
David Einhorn''s hedge fund Greenlight Capital initiated new positions in Global Payments (GPN), Capri Holdings (CPRI) and Galapagos (GLPG). The new positions were revealed in the funds
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
12:40pm, Wednesday, 19'th Jan 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
Orphazyme Preannounces Positive FY21 Results
Orphazyme A/S (NASDAQ: ORPH) announced an upward revision
JYSELECA®▼ (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREAT BRITAIN
09:01pm, Tuesday, 18'th Jan 2022 GlobeNewswire Inc.
Mechelen, Belgium; 18 January 2022; 22.01 CET; Galapagos NV (Euronext & Nasdaq: GLPG) announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing aut
JYSELECA®▼ (FILGOTINIB) KRIJGT VERGUNNING VOOR DE BEHANDELING VAN VOLWASSEN PATIËNTEN MET MATIGE TOT ERNSTIGE ACTIEVE COLITIS ULCEROSA IN GROOT-BRITTANNIË
09:01pm, Tuesday, 18'th Jan 2022 GlobeNewswire Inc.
Mechelen, België; 18 januari 2022; 22.01 CET; Galapagos NV (Euronext & Nasdaq: GLPG) maakt vandaag bekend dat het Medicines and Healthcare products Regulatory Agency (MHRA) de handelsvergunning heef